您的位置: 首页 > 农业专利 > 详情页

Peptide GLP-2 agonists
专利权人:
FERRING BV
发明人:
ALAGARSAMY, SUDARKODI,JIANG, GUANGCHENG,RIVIERE, PIERRE,SCHTEINGART, CLAUDIO,SUEIRAS-DIAZ, JAVIER,WISNIEWSKI, KAZIMIERZ
申请号:
ES10825678
公开号:
ES2530615T3
申请日:
2010.10.21
申请国别(地区):
ES
年份:
2015
代理人:
摘要:
Compound of formula I: ** formula ** in which: R1 is selected from the group consisting of H, alkyl, aralkyl and aryl; a is chosen from the group consisting of 0, 1, 2, 3, 4, 5, 6 and 7; R2 is a heteroaryl; b is 1 or 2; R3 and R4 are each independently selected from the group consisting of H and alkyl; c and d are each chosen independently of the group consisting of 0 and 1; R5 is methyl; e is 3; R6 is selected from the group consisting of H, alkyl, cycloalkyl, aryl, biaryl, heteroaryl and -C (O) -NH2, in which the amino acid formed with the side chain in R6 is in the D configuration; f is chosen from the group consisting of 0, 1, 2 and 3, with the proviso that if R6 is different from H, f is not 0; R7 is selected from the group consisting of alkyl, cycloalkyl, aryl, biaryl, diaryl, heteroaryl and -C (O) -NH2; g is chosen from the group consisting of 1, 2 and 3; R8 is selected from the group consisting of H, alkyl, -CH (OH) -CH3; h is chosen from the group consisting of 0, 1, 2 and 3; X1 is Gln or Arg; X2, X3 and X4 are each independently present or absent and, if present, are independently selected from the group consisting of Val, Leu, Ile, Ser, Thr, Asp and Glu; Z is NR9R10 or OH, wherein: R9 and R10 are each independently selected from the group consisting of hydrogen, alkyl, heteroalkyl, cycloalkyl, aryl, heteroaryl, heteroaralkyl, aralkyl and (CH2) x - [(CH2) 2- O] and- (CH2) x- [NH-C (O) -CH2-O-CH2] zC (O) -NHR11, in which: R11 is H or - [(CH2) 2-O] and- ( CH2) xC (O) -NH2 each x is independently selected from the group consisting of 0, 1, 2 and 3, each and is independently selected from the group consisting of 3, 4, 5 and 6, z is 0 or 1, and R9 and R10 are optionally linked to form a 4- to 7-membered ring that may be a heterocycle or a heteroaryl; and pharmaceutically acceptable salts thereof.Compuesto de fórmula I:**fórmula** en la que: R1 se elige del grupo que consiste en H, alquilo, aralquilo y arilo; a se elige del grupo que consiste en 0, 1, 2, 3, 4, 5
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充